Ucephan and Keratoconjunctivitis - from FDA reports


Summary

There is no Keratoconjunctivitis reported by people who take Ucephan yet. This review analyzes which people have Keratoconjunctivitis with Ucephan. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Ucephan and have Keratoconjunctivitis, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 20, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Keratoconjunctivitis when taking Ucephan?

Expand the study to include all drugs with the same ingredients

Keratoconjunctivitis and drugs with ingredients of sodium benzoate; sodium phenylacetate.

Expand the study to include reports from both FDA and eHealthMe

Keratoconjunctivitis and Ucephan from FDA and eHealthMe reports

Ucephan

Ucephan has active ingredients of sodium benzoate; sodium phenylacetate. (latest outcomes from Ucephan 1 users)

Keratoconjunctivitis

Keratoconjunctivitis (inflammation of the cornea and conjunctiva) has been reported by people with chemotherapy, hormone replacement therapy (latest reports from 94 Keratoconjunctivitis patients).

Browse all side effects of Ucephan

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Keratoconjunctivitis

Keratoconjunctivitis

Could your condition cause Keratoconjunctivitis

Keratoconjunctivitis

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Ucephan and have Keratoconjunctivitis.